By continuing browsing this website, you accept the use of cookies to help us improve your user experience. Read more.

Lesaffre announces the full acquisition of Gnosis, an Italian biotechnology company specialized in the development, manufacturing and sale of fermentation-derived ingredients and natural finished products for use in the pharmaceutical, nutraceutical, veterinary and cosmetic industries, three years after acquiring a majority shareholding of this company.

Download the press release